Giles Watts

490 total citations
7 papers, 342 citations indexed

About

Giles Watts is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Giles Watts has authored 7 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 2 papers in Epidemiology. Recurrent topics in Giles Watts's work include Amyotrophic Lateral Sclerosis Research (4 papers), Autophagy in Disease and Therapy (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Giles Watts is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (4 papers), Autophagy in Disease and Therapy (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Giles Watts collaborates with scholars based in United States, United Kingdom and Germany. Giles Watts's co-authors include Virginia Kimonis, Jouni Vesa, Erin Fulchiero, Christopher Nguyen, Tahseen Mozaffar, Jack Morrison, Katrina J. Llewellyn, Jogeshwar Mukherjee, John H. Weiss and Mallikarjun Badadani and has published in prestigious journals such as PLoS ONE, The American Journal of Human Genetics and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Giles Watts

7 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giles Watts United States 7 165 143 115 87 54 7 342
Eric Dec United States 5 134 0.8× 159 1.1× 97 0.8× 74 0.9× 50 0.9× 5 300
Inga Hansson Sweden 8 139 0.8× 68 0.5× 82 0.7× 42 0.5× 81 1.5× 8 322
Ria Thomas United States 9 154 0.9× 101 0.7× 89 0.8× 29 0.3× 49 0.9× 13 304
Lydia Chang United States 6 148 0.9× 149 1.0× 57 0.5× 49 0.6× 36 0.7× 7 478
Ana Kolicheski United States 11 105 0.6× 82 0.6× 48 0.4× 36 0.4× 26 0.5× 18 343
Jennifer Lévy United States 10 415 2.5× 142 1.0× 269 2.3× 37 0.4× 103 1.9× 11 619
Kirsty J. McMillan United Kingdom 6 249 1.5× 107 0.7× 175 1.5× 62 0.7× 67 1.2× 7 387
Cécile Otten Germany 12 315 1.9× 39 0.3× 153 1.3× 50 0.6× 30 0.6× 18 438
Anni Evilä Finland 12 525 3.2× 76 0.5× 75 0.7× 52 0.6× 141 2.6× 20 644

Countries citing papers authored by Giles Watts

Since Specialization
Citations

This map shows the geographic impact of Giles Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giles Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giles Watts more than expected).

Fields of papers citing papers by Giles Watts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giles Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giles Watts. The network helps show where Giles Watts may publish in the future.

Co-authorship network of co-authors of Giles Watts

This figure shows the co-authorship network connecting the top 25 collaborators of Giles Watts. A scholar is included among the top collaborators of Giles Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giles Watts. Giles Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Morrison, Jack, et al.. (2020). Assessing the performance of quantity and quality metrics using the QIAGEN Investigator® Quantiplex® pro RGQ kit. Science & Justice. 60(4). 388–397. 10 indexed citations
2.
Morrison, Jack, Giles Watts, Glyn Hobbs, & Nick Dawnay. (2018). Field-based detection of biological samples for forensic analysis: Established techniques, novel tools, and future innovations. Forensic Science International. 285. 147–160. 26 indexed citations
3.
Nalbandian, Angèle, Katrina J. Llewellyn, Masashi Kitazawa, et al.. (2012). The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology. PLoS ONE. 7(9). e46308–e46308. 52 indexed citations
4.
Nalbandian, Angèle, Katrina J. Llewellyn, Mallikarjun Badadani, et al.. (2012). A progressive translational mouse model of human valosin‐containing protein disease: The VCPR155H/+ mouse. Muscle & Nerve. 47(2). 260–270. 51 indexed citations
5.
Camacho‐Vanegas, Olga, Sandra Catalina Camacho, Jacob E. Till, et al.. (2012). Primate Genome Gain and Loss: A Bone Dysplasia, Muscular Dystrophy, and Bone Cancer Syndrome Resulting from Mutated Retroviral-Derived MTAP Transcripts. The American Journal of Human Genetics. 90(4). 614–627. 23 indexed citations
6.
Kimonis, Virginia, Sandra Donkervoort, & Giles Watts. (2011). Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia. eScholarship (California Digital Library). 11 indexed citations
7.
Kimonis, Virginia, Erin Fulchiero, Jouni Vesa, & Giles Watts. (2008). VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: Review of a unique disorder. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1782(12). 744–748. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026